Frequency of germline and somatic BRCA1 mutations in ovarian cancer

Clinical Cancer Research

Volumn 4, Issue 10, 1998, Pages 2433-2437

  Berchuck, Andrew ^a   Heron, Kerrie Ann ^a   Carney, Michael E ^a   Lancaster, Johnathan M ^a   Fraser, Elisa G ^b   Vinson, Vickie L ^b   Deffenbaugh, Amie M ^b   Miron, Alexander ^a   Marks, Jeffrey R ^a   Futreal, P Andrew ^a   Frank, Tom S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Utah   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; FAMILY HISTORY; FEMALE; GENE LOCUS; GENE MUTATION; GYNECOLOGIC CANCER; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS;

EID: 0031755914     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Stratton, J. F., Gayther, S. A., Russell, P., Dearden, J., Gore, M., Blake, P., Easton, D., and Ponder, B. A. Contribution of BRCA1 mutations to ovarian cancer. N. Engl. J. Med., 336: 1125-1130, 1997.
2. Szabo, C. I., and King, M. C. Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet., 60: 1013-1020, 1997.
3. Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., Zlotogora, J., Heching, N., and Peretz, T. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet., 60: 505-514, 1997.
4. Muto, M. G., Cramer, D. W., Tangir, J., Berkowitz, R., and Mok, S. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res., 56: 1250-1252, 1996.
5. Jacobs, I. J., Smith, S., Wiseman, R., Futreal, A., Berchuck, A., Ponder, B. J., and Bast, R. C. A deletion unit on chromosome 17q defined by loss of heterozygosity in epithelial ovarian cancer and a benign serous cystadenoma. Cancer Res., 53: 1218-1221, 1993.
6. Schildkraut, J. M., Collins, N. K., Dent, G. A., Tucker, J. A., Barrett, J. C., Berchuck, A., and Boyd, J. Loss of heterozygosity on chromosome 17q 11-21 in cancers of women who have both breast and ovarian cancer. Am. J. Obstet. Gynecol., 172: 908-913, 1995.
7. Takahashi, H., Behbakht, K., McGovern, P. E., Chiu, H. C., Couch, F. J., Weber, B. L., Friedman, L. S., King, M. C., Furusato, M., and Livolsi, V. A. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res., 55: 2998-3002, 1995.
8. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., and Miki, Y. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
9. Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C., and Frank, T. S. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet., 9: 439-443, 1995.
10. Hosking, L., Trowsdale, J., Nicolai, H., Solomon, E., Foulkes, W., Stamp, G., Signer, E., and Jeffreys, A. A somatic BRCA1 mutation in an ovarian tumour. Nat. Genet., 9: 343-344, 1995.
11. Smith, S. A., Easton, D. F., Evans, D. G., and Ponder, B. A. Allele losses in the region 17q 12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet., 2: 128-131, 1992.
12. Shattuck-Eidens, D., Oliphant, A., McClure, M., McBride, C., Gupte, J., Rubano, T., Pruss, D., Tavtigian, S. V., Teng, D. H., Adey, N., Staebell, M., Gumpper, K., Lundstrom, R., Hulick, M., Kelly, M., Holmen, J., Lingenfelter, B., Manley, S., Fujimura, F., Luce, M., Ward, B., Cannon-Albright, L., Steele, L., Offit, K., Gilewski, T., Norton, L., Brown, K., Schulz, C., Hampel, H., Schluger, A., Giulotto, E., Zoli, W., Ravaioli, A., Nevanlinna, H., Pyrhonen, S., Rowley, P., Loader, S., Osborne, M. P., Daly, M., Tepler, I., Weinstein, P. L., Scalia, J. L., Michaelson, R., Scott, R. J., Radice, P., Pierotti, M. A., Garber, J. E., Isaacs, C., Peshkin, B., Lippman, M. E., Dosik, M. H., Caligo, M. A., Greensteir, R. M., Pilarski, R., Weber, B., Burgemeister, R., Frank, T. S., Skolnick, M. H., and Thomas, A. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. J. Am. Med. Assoc., 278: 1242-1250, 1997.
13. Couch, F. J., and Weber, B. L. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum. Mutat., 8: 8-18, 1996.
14. Petrij-Bosch, A., Peelen, T., van, V. M., van, E. R., Olmer, R., Drusedau, M., Hogervorst, F. B., Hageman, S., Arts, P. J., Ligtenberg, M. J., Meijers-Heijboer, H., Klijn, J. G., Vasen, H. F., Cornelisse, C. J., van't, V. L. J., Bakker, E., van, O. G. J., and Devilee, P. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat. Genet., 17: 341-345, 1997.
15. Tirkkonen, M., Johannsson, O., Agnarrsson, B. A., Olsson, H., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J., Barkardottir, R. B., Borg, A., and Kallioniemi, O. P. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57: 1222-1227, 1997.
16. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88: 265-275, 1997.
17. Takano, M., Aida, H., Tsuneki, I., Takakuwa, K., Hasegawa, I., Tanaka, H., Saito, M., Tsuji, S., Sonoda, T., Hatae, M., Chen, J. T., Takahashi, K., Hasegawa, K., Toyoda, N., Saito, N., Yakushiji, M., Araki, T., and Tanaka, K. Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan. Jpn. J. Cancer Res., 88: 407-413, 1997.
18. Matsushima, M., Kobayashi, K., Emi, M., Saito, H., Saito, J., Suzumori, K., and Nakamura, Y. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation. Hum. Mol. Genet., 4: 1953-1956, 1995.
19. Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., Livolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., Lynch, H. T., and Boyd, J. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N. Engl. J. Med., 335: 1413-1416, 1996.
20. Aida, H., Takakuwa, K., Nagata, H., Tsuneki, I., Takano, M., Tsuji, S., Takahashi, T., Sonoda, T., Hatae, M., Takahashi, K., Hasegawa, K., Mizunuma, H., Toyoda, N., Kamata, H., Torii, Y., Saito, N., Tanaka, K., Yakushiji, M., and Araki, T. Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1. Clin. Cancer Res., 4: 235-240, 1998.
21. Johannsson, O. T., Ranstram, J., Borg, A., and Olsson, H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J. Clin. Oncol., 16: 397-404, 1998.
22. Hartmann, L., Podratz, K., Keeney, G., Kamel, N., Edmonson, J., Grill, J., Su, J., Katzmann, J., and Roche, P. Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J. Clin. Oncol., 12: 64-69, 1994.
23. Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J. T., Dodge, R., Clarke-Pearson, P., Marks, S., McKenzie, S., Yin, S., and Bast, R. C., Jr. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50:4087-4091, 1990.